Literature DB >> 16508719

Diagnosis and treatment of hypopituitarism: an update.

M O van Aken1, S W J Lamberts.   

Abstract

Diagnosis and treatment of patients with hypopituitarism needs careful clinical evaluation and individual optimization. Symptoms of hypopituitarism are variable, often insidious in onset and dependent on the degree of hormone deficiency. Diagnosis of hypopituitarism can be straightforward by measuring reduced basal hormone levels. Frequently, dynamic stimulation tests are indicated in equivocal basal hormone levels or to diagnose partial hormone deficiencies. Knowledge of the use and limitations of these dynamic tests is mandatory for proper interpretation. Hormone replacement therapy should be individualized, taking into account possible interactions. Persisting symptoms and reduced quality of life are frequently reported, explained by, at least in part, intrinsic imperfections of hormone replacement strategies in mimicking normal hormone secretion. In the present overview, the principles of diagnosis and treatment of hypopituitarism are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16508719     DOI: 10.1007/s11102-006-6039-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  65 in total

1.  Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests.

Authors:  Xiao-Dan Qu; Irene T Gaw Gonzalo; Mohammed Y Al Sayed; Pejman Cohan; Peter D Christenson; Ronald S Swerdloff; Daniel F Kelly; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

2.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

Authors:  G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; E Arvat; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 3.  Pituitary insufficiency.

Authors:  S W Lamberts; W W de Herder; A J van der Lely
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

Review 4.  Biochemical markers of individual response to growth hormone replacement in adults.

Authors:  J P Monson
Journal:  Horm Res       Date:  2001

5.  Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.

Authors:  E Ferretti; L Persani; M L Jaffrain-Rea; S Giambona; G Tamburrano; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

6.  A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.

Authors:  Andreas Jostel; Annice Mukherjee; Jan Alenfall; Linda Smethurst; Stephen M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2005-05       Impact factor: 3.478

7.  Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.

Authors:  Annamaria Colao; Giovanni Vitale; Paolo Cappabianca; Francesco Briganti; Antonio Ciccarelli; Michele De Rosa; Stefano Zarrilli; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

8.  Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.

Authors:  J Blomgren; B Ekman; P O Andersson; H J Arnqvist
Journal:  Scand J Clin Lab Invest       Date:  2004-04       Impact factor: 1.713

9.  Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.

Authors:  Leon A Adams; Ariel Feldstein; Keith D Lindor; Paul Angulo
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

10.  Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

Authors:  I A Malik; P Foy; M Wallymahmed; J P H Wilding; I A MacFarlane
Journal:  Clin Endocrinol (Oxf)       Date:  2003-07       Impact factor: 3.478

View more
  13 in total

Review 1.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 2.  Hormones and the bone marrow: panhypopituitarism and pancytopenia in a man with a pituitary adenoma.

Authors:  Dianna Lang; Jennifer S Mead; David B Sykes
Journal:  J Gen Intern Med       Date:  2015-05       Impact factor: 5.128

3.  The Missing Link: A Case of Absent Pituitary Infundibulum and Ectopic Neurohypophysis in a Pediatric Patient with Heterotaxy Syndrome.

Authors:  Adil Omer; Dana Haddad; Leszek Pisinski; Alan V Krauthamer
Journal:  J Radiol Case Rep       Date:  2017-09-30

4.  Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors.

Authors:  Go Hun Seo; Jin-Ho Choi; Yoon-Myung Kim; Kyung-Nam Koh; Ho Joon Im; Young Shin Ra; Han-Wook Yoo
Journal:  J Neurooncol       Date:  2018-01-19       Impact factor: 4.130

Review 5.  Hypopituitarism.

Authors:  Paola Ascoli; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

6.  An unusual suspect causing behavioural problems and pituitary failure in a child.

Authors:  Adam Charles Heathcote; Justin Conrad Rosen Wormald; Richard Stocks
Journal:  BMJ Case Rep       Date:  2012-12-14

7.  Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.

Authors:  R Cozzi; G Lasio; A Cardia; G Felisati; M Montini; R Attanasio
Journal:  J Endocrinol Invest       Date:  2009-04-29       Impact factor: 4.256

Review 8.  Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic-pituitary-gonadal, hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes dysfunction.

Authors:  L Curtò; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2016-05-21       Impact factor: 4.256

9.  Evolving hypopituitarism as a consequence of traumatic brain injury (TBI) in childhood - call for attention.

Authors:  Milica Medic-Stojanoska; Sandra Pekic; Nikola Curic; Dragana Djilas-Ivanovic; Vera Popovic
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

10.  Measurement of height velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury.

Authors:  S Bellone; S Einaudi; M Caputo; F Prodam; A Busti; S Belcastro; S Parlamento; M Zavattaro; F Verna; C Bondone; D Tessaris; V Gasco; G Bona; G Aimaretti
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.